Skip to content

A clinical study of nimbapatra tila kalka application in infected wound

An open randomized controlled clinical trial for shodhana effect of nimbapatra tila kalka in management of dushtavrana - NIL

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/03/082182
Enrollment
68
Registered
2025-03-12
Start date
Unknown
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L088- Other specified local infections of the skin and subcutaneous tissue

Interventions

None listed

Sponsors

Dr Aishwarya Endait
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1) patient having infected wound will be included 2) wound size 5-7 sq.cm in length in breath 3) depth of wound upto 1 cm

Exclusion criteria

Exclusion criteria: 1) Patient with HIV,HBsAG,Tuberculosis 2)Maligant ulcer 3)Patient with burn 4)Dushtavrana on head, neck region 5)Features showing gangrene

Design outcomes

Primary

MeasureTime frame
To evaluate the shodhan effect of nimbapatra tila kalka in management of dushta varnaTimepoint: 15 days

Secondary

MeasureTime frame
povidone iodine ointment is effective in the management of dushta vranaTimepoint: 15 days

Countries

India

Contacts

Public ContactDr Vijay Sarjerao Dange

Hon Shri Annasaheb Dange Ayurved Medical college Post Graduate And Research Center

drvijaydange@gmail.com8600600181

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026